Eye care availability and access among individuals with diabetes, diabetic retinopathy, or age-related macular degeneration

JAMA Ophthalmology

Volumn 132, Issue 4, 2014, Pages 471-477

  Gibson, Diane M ^a  

^a CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE CARE; EYE EXAMINATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PERSONNEL; MEDICARE; OPHTHALMOLOGIST; OPTOMETRIST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; SELF REPORT;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HEALTH PERSONNEL; HEALTH SERVICES ACCESSIBILITY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; NUTRITION SURVEYS; OPHTHALMOLOGY; OPTOMETRY; UNITED STATES;

EID: 84898630271     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.7682     Document Type: Article

References (44)

1. Zhang X, Andersen R, Saaddine JB, Beckles GL, Duenas MR, Lee PP. Measuring access to eye care. Ophthalmic Epidemiol. 2008; 15 (6): 418-425.
2. Congdon N, O'Colmain B, Klaver CC, et al; Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 2004; 122 (4): 477-485.
3. Kempen JH, O'Colmain BJ, Leske MC, et al; Eye Diseases Prevalence Research Group. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004; 122 (4): 552-563.
4. Zhang X, Saaddine JB, Chou CF, et al. Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA. 2010; 304 (6): 649-656.
5. Klein R, Klein B. Vision disorders in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995: 293-297.
6. Friedman DS, O'Colmain BJ, Muñoz B, et al; Eye Diseases Prevalence Research Group. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004; 122 (4): 564-572.
7. Klein R, Chou CF, Klein BE, Zhang X, Meuer SM, Saaddine JB. Prevalence of age-related macular degeneration in the US population. Arch Ophthalmol. 2011; 129 (1): 75-80.
8. Gibson DM. Diabetic retinopathy and age-related macular degeneration in the U.S. Am J Prev Med. 2012; 43 (1): 48-54.
9. American Academy of Ophthalmology. Preferred Practice Pattern: Diabetic Retinopathy. San Francisco, CA: American Academy of Ophthalmology; 2008.
10. American Academy of Ophthalmology. Preferred Practice Pattern: Age-Related Macular Degeneration. San Francisco, CA: American Academy of Ophthalmology; 2008.
11. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329 (14): 977-986.
12. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. 1998; 317 (7160): 703-713.
13. Avery RF, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006; 113 (10): 1695.e1-1695.15.
14. Bressler NM, Edwards AR, Beck RW, et al; Diabetic Retinopathy Clinical Research Network. Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation. Arch Ophthalmol. 2009; 127 (12): 1566-1571.
15. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001; 119 (10): 1417-1436.
16. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006; 355 (14): 1419-1431.
17. Brown DM, Kaiser PK, MichelsM, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006; 355 (14): 1432-1444.
18. Coleman HR, Chan CC, Ferris FL III, Chew EY. Age-related macular degeneration. Lancet. 2008; 372 (9652): 1835-1845.
19. Sloan FA, Brown DS, Carlisle ES, Picone GA, Lee PP. Monitoring visual status. Health Serv Res. 2004; 39 (5): 1429-1448.
20. Wang F, Javitt JC. Eye care for elderly Americans with diabetes mellitus. Ophthalmology. 1996; 103 (11): 1744-1750.
21. Centers for Disease Control and Prevention; National Center for Health Statistics. Analytic and Reporting Guidelines: National Health and Nutrition Examination Survey. 2005. www.cdc.gov/nchs/.../nhanes-analytic-guidelines-dec- 2005.pdf. Accessed August 18, 2010.
22. National Health and Nutrition Examination Survey. Ophthalmology - Retinal Imaging: Data Documentation, Codebook, Frequencies. Centers for Disease Control and Prevention. 2010. http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/OPXRET-E. htm. Accessed August 13, 2010.
23. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs. Ophthalmology. 1991; 98 (5) (suppl): 786-806.
24. Klein R, DavisMD, Magli YL, Segal P, Klein BE, Hubbard L. The Wisconsin age-related maculopathy grading system. Ophthalmology. 1991; 98 (7): 1128-1134.
25. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2010; 33 (suppl 1): S62-S69.
26. Wilkinson CP, Ferris FL III, Klein RE, et al; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003; 110 (9): 1677-1682.
27. Rein DB, Wittenborn JS, Zhang X, et al; Vision Cost-Effectiveness Study Group. The cost-effectiveness of three screening alternatives for people with diabetes with no or early diabetic retinopathy. Health Serv Res. 2011; 46 (5): 1534-1561.
28. National Diabetes Data Group. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 1995.
29. US Department of Health and Human Services. Area Health Resource Files (AHRF). Rockville, MD: Health Resources and Services Administration, Bureau of Health Professions; 2012-2013.
30. Korn EL, Graubard BI. Analysis of Health Surveys. New York, NY: Wiley; 1999.
31. Ioannidis JP, Hozo I, Djulbegovic B. Optimal type I and type II error pairs when the available sample size is fixed. J Clin Epidemiol. 2013; 66 (8): 903-910, e2.
32. Lazaridis EN, Qiu C, Kraft SK, Marrero DG. Same eyes, different doctors. Diabetes Care. 1997; 20 (7): 1073-1077.
33. Bressler NM. Early detection and treatment of neovascular age-related macular degeneration. J AmBoard Fam Pract. 2002; 15 (2): 142-152.
34. White AJ, Doksum T, White C.Workforce projections for optometry. Optometry. 2000; 71 (5): 284-300.
35. Lee PP, Hoskins HD Jr, Parke DWIII. Access to care. Arch Ophthalmol. 2007; 125 (3): 406-410.
36. Jones S, Edwards RT. Diabetic retinopathy screening. Diabet Med. 2010; 27 (3): 249-256.
37. Taylor CR, Merin LM, Salunga AM, et al. Improving diabetic retinopathy screening ratios using telemedicine-based digital retinal imaging technology. Diabetes Care. 2007; 30 (3): 574-578.
38. Au A, Gupta O. The economics of telemedicine for vitreoretinal diseases. Curr Opin Ophthalmol. 2011; 22 (3): 194-198.
39. Zhang X, Norris SL, Saadine J, et al. Effectiveness of interventions to promote screening for diabetic retinopathy. Am J Prev Med. 2007; 33 (4): 318-335.
40. Kelly SP, Wallwork I, Haider D, Qureshi K. Teleophthalmology with optical coherence tomography imaging in community optometry. Clin Ophthalmol. 2011; 5: 1673-1678.
41. Hanson C, Tennant MT, Rudnisky CJ. Optometric referrals to retina specialists. Telemed J E Health. 2008; 14 (5): 441-445.
42. Lee PP, Hoskins HD Jr, Smith RE, Hutchinson BT, Wong BA. Access to eye care. Arch Ophthalmol. 2007; 125 (3): 403-405.
43. Liu L, Swanson M. Improving patient outcomes. Clin Optom. 2013; 5: 1-12.
44. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Dept of Health and Human Services, Centers for Disease Control and Prevention; 2011.